{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T16:39:18Z","timestamp":1776530358479,"version":"3.51.2"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:00:00Z","timestamp":1776470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:00:00Z","timestamp":1776470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-026-06418-w","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T15:49:09Z","timestamp":1776527349000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Biopsy Gleason score 5\u00a0+\u2009\u00a04 predicts worse outcomes than 4\u00a0+\u00a05 after robot-assisted radical prostatectomy: a nationwide multicenter cohort study"],"prefix":"10.1007","volume":"44","author":[{"given":"Kimihiro","family":"Shimatani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shingo","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Sumiyoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryoichi","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakatsu","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Iguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshifumi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Yokozeki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Iwamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Kohei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryoma","family":"Kurahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuya","family":"Sekine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuro","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromitsu","family":"Negoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shusuke","family":"Akamatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,18]]},"reference":[{"key":"6418_CR1","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.6004\/jnccn.2023.0050","volume":"21","author":"EM Schaeffer","year":"2023","unstructured":"Schaeffer EM, Srinivas S, Adra N et al (2023) Prostate cancer, version 4.2023, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 21:1067\u20131096","journal-title":"J Natl Compr Canc Netw"},{"key":"6418_CR2","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","volume":"86","author":"P Cornford","year":"2024","unstructured":"Cornford P, van den Bergh RCN, Briers E et al (2024) EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer-2024 update. Part I: screening, diagnosis, and local treatment with curative intent. Eur Urol 86:148\u2013163","journal-title":"Eur Urol"},{"key":"6418_CR3","doi-asserted-by":"crossref","unstructured":"Epstein JI, Egevad L, Amin MB et al (2016) The 2014 international society of urological pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system. Am J Surg Pathol 40:244\u2013252","DOI":"10.1097\/PAS.0000000000000530"},{"key":"6418_CR4","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.euo.2023.11.002","volume":"7","author":"L Egevad","year":"2024","unstructured":"Egevad L, Micoli C, Samaratunga H et al (2024) Prognosis of Gleason score 9\u201310 prostatic adenocarcinoma in needle biopsies: a nationwide population-based study. Eur Urol Oncol 7:213\u2013221","journal-title":"Eur Urol Oncol"},{"key":"6418_CR5","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.clon.2023.03.018","volume":"35","author":"S Chilukuri","year":"2023","unstructured":"Chilukuri S, Mallick I, Agrawal A et al (2023) Multi-institutional clinical outcomes of biopsy Gleason grade group 5 prostate cancers treated with contemporary high-dose radiation and long-term androgen deprivation therapy. Clin Oncol (R Coll Radiol) 35:454\u2013462","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"6418_CR6","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1186\/s12885-020-06880-8","volume":"20","author":"S Taguchi","year":"2020","unstructured":"Taguchi S, Uemura Y, Fujimura T et al (2020) Quantification of the individual risk of each Gleason pattern, including tertiary Gleason pattern 5, after radical prostatectomy: development of the modified Gleason grade grouping (mGGG) model. BMC Cancer 20:371","journal-title":"BMC Cancer"},{"key":"6418_CR7","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.eururo.2016.11.032","volume":"71","author":"MS Leapman","year":"2017","unstructured":"Leapman MS, Cowan JE, Simko J et al (2017) Application of a prognostic Gleason grade grouping system to assess distant prostate cancer outcomes. Eur Urol 71:750\u2013759","journal-title":"Eur Urol"},{"key":"6418_CR8","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.clgc.2020.08.001","volume":"19","author":"R Kamitani","year":"2021","unstructured":"Kamitani R, Matsumoto K, Kosaka T et al (2021) Evaluation of Gleason grade group 5 in a contemporary prostate cancer grading system and literature review. Clin Genitourin Cancer 19:69\u201375e5","journal-title":"Clin Genitourin Cancer"},{"key":"6418_CR9","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/pros.23265","volume":"77","author":"P Dell\u2019Oglio","year":"2017","unstructured":"Dell\u2019Oglio P, Karnes RJ, Gandaglia G et al (2017) The new prostate cancer grading system does not improve prediction of clinical recurrence after radical prostatectomy: results of a large, two-center validation study. Prostate 77:263\u2013273","journal-title":"Prostate"},{"key":"6418_CR10","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1111\/bju.13488","volume":"118","author":"DE Spratt","year":"2016","unstructured":"Spratt DE, Cole AI, Palapattu GS et al (2016) Independent surgical validation of the new prostate cancer grade-grouping system. BJU Int 118:763\u2013769","journal-title":"BJU Int"},{"key":"6418_CR11","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/pcan.2016.18","volume":"19","author":"DE Spratt","year":"2016","unstructured":"Spratt DE, Jackson WC, Abugharib A et al (2016) Independent validation of the prognostic capacity of the ISUP prostate cancer grade grouping system for radiation treated patients with long-term follow-up. Prostate Cancer Prostatic Dis 19:292\u2013297","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"6418_CR12","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1111\/j.1464-410X.2012.11611.x","volume":"111","author":"PM Pierorazio","year":"2013","unstructured":"Pierorazio PM, Walsh PC, Partin AW, Epstein JI (2013) Prognostic Gleason grade grouping: data based on the modified Gleason scoring system: prognostic Gleason grade grouping. BJU Int 111:753\u2013760","journal-title":"BJU Int"},{"key":"6418_CR13","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.eururo.2015.11.036","volume":"69","author":"S Loeb","year":"2016","unstructured":"Loeb S, Folkvaljon Y, Robinson D et al (2016) Evaluation of the 2015 Gleason grade groups in a nationwide population-based cohort. Eur Urol 69:1135\u20131141","journal-title":"Eur Urol"},{"key":"6418_CR14","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.eururo.2015.06.046","volume":"69","author":"JI Epstein","year":"2016","unstructured":"Epstein JI, Zelefsky MJ, Sjoberg DD et al (2016) A contemporary prostate cancer grading system: a validated alternative to the Gleason score. Eur Urol 69:428\u2013435","journal-title":"Eur Urol"},{"key":"6418_CR15","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.euf.2020.01.008","volume":"6","author":"D Tilki","year":"2020","unstructured":"Tilki D, W\u00fcrnschimmel C, Preisser F et al (2020) The significance of primary biopsy Gleason 5 in patients with grade group 5 prostate cancer. Eur Urol Focus 6:255\u2013258","journal-title":"Eur Urol Focus"},{"key":"6418_CR16","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.euf.2021.04.011","volume":"8","author":"M Wenzel","year":"2022","unstructured":"Wenzel M, W\u00fcrnschimmel C, Chierigo F et al (2022) Pattern of biopsy Gleason grade group 5 (4\u2009+\u20095 vs 5\u2009+\u20094 vs 5\u2009+\u20095) predicts survival after radical prostatectomy or external beam radiation therapy. Eur Urol Focus 8:710\u2013717","journal-title":"Eur Urol Focus"},{"key":"6418_CR17","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/JU.0000000000002757","volume":"208","author":"JA Eastham","year":"2022","unstructured":"Eastham JA, Auffenberg GB, Barocas DA et al (2022) Clinically localized prostate cancer: AUA\/ASTRO guideline, part I: introduction, risk assessment, staging, and risk-based management. J Urol 208:10\u201318","journal-title":"J Urol"},{"key":"6418_CR18","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1001\/jama.280.11.969","volume":"280","author":"AV D\u2019Amico","year":"1998","unstructured":"D\u2019Amico AV, Whittington R, Malkowicz SB et al (1998) Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280:969\u2013974","journal-title":"JAMA"},{"key":"6418_CR19","doi-asserted-by":"publisher","first-page":"5847","DOI":"10.1038\/s41598-024-56570-9","volume":"14","author":"M Kubota","year":"2024","unstructured":"Kubota M, Kawakita M, Yoshida S et al (2024) Effects of thienopyridine class antiplatelets on bleeding outcomes following robot-assisted radical prostatectomy. Sci Rep 14:5847","journal-title":"Sci Rep"},{"key":"6418_CR20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00345-024-05363-w","volume":"43","author":"H Hagimoto","year":"2024","unstructured":"Hagimoto H, Kubota M, Matsui Y et al (2024) Impact of neurovascular bundle preservation on biochemical recurrence after robot-assisted radical prostatectomy for high-risk prostate cancer. World J Urol 43:43","journal-title":"World J Urol"},{"key":"6418_CR21","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1002\/pros.24875","volume":"85","author":"T Kambe","year":"2025","unstructured":"Kambe T, Kubota M, Yamasaki T et al (2025) Impact of neoadjuvant chemohormonal therapy with GnRH antagonist and low-dose estramustine in very high-risk prostate cancer undergoing robotic radical prostatectomy. Prostate 85:684\u2013692","journal-title":"Prostate"},{"key":"6418_CR22","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.juro.2006.10.097","volume":"177","author":"MS Cookson","year":"2007","unstructured":"Cookson MS, Aus G, Burnett AL et al (2007) Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for localized prostate cancer update panel report and recommendations for a standard in the reporting of surgical outcomes. J Urol 177:540\u2013545","journal-title":"J Urol"},{"key":"6418_CR23","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.eururo.2020.09.046","volume":"79","author":"P Cornford","year":"2021","unstructured":"Cornford P, van den Bergh RCN, Briers E et al (2021) EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer. Part II-2020 update: treatment of relapsing and metastatic prostate cancer. Eur Urol 79:263\u2013282","journal-title":"Eur Urol"},{"key":"6418_CR24","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.juro.2009.11.027","volume":"183","author":"AM Cronin","year":"2010","unstructured":"Cronin AM, Godoy G, Vickers AJ (2010) Definition of biochemical recurrence after radical prostatectomy does not substantially impact prognostic factor estimates. J Urol 183:984\u2013989","journal-title":"J Urol"},{"key":"6418_CR25","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1097\/JU.0000000000003055","volume":"209","author":"A Martini","year":"2023","unstructured":"Martini A, Valerio M (2023) An algorithm to personalize nerve sparing in men with unilateral high-risk prostate cancer. Reply J Urol 209:325","journal-title":"Reply J Urol"},{"key":"6418_CR26","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/JU.0000000000000760","volume":"204","author":"TFW Soeterik","year":"2020","unstructured":"Soeterik TFW, van Melick HHE, Dijksman LM et al (2020) Nerve sparing during robot-assisted radical prostatectomy increases the risk of ipsilateral positive surgical margins. J Urol 204:91\u201395","journal-title":"J Urol"},{"key":"6418_CR27","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1136\/jclinpath-2016-204276","volume":"70","author":"J Yeong","year":"2017","unstructured":"Yeong J, Sultana R, Teo J et al (2017) Gleason grade grouping of prostate cancer is of prognostic value in Asian men. J Clin Pathol 70:745\u2013753","journal-title":"J Clin Pathol"},{"key":"6418_CR28","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/bju.15298","volume":"127","author":"L Egevad","year":"2021","unstructured":"Egevad L, Delahunt B, Bostwick DG et al (2021) Prostate cancer grading, time to go back to the future. BJU Int 127:165\u2013168","journal-title":"BJU Int"},{"key":"6418_CR29","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1245\/s10434-013-2996-4","volume":"20","author":"SK Lim","year":"2013","unstructured":"Lim SK, Kim KH, Shin T-Y et al (2013) Gleason 5\u2009+\u20094 has worse oncological and pathological outcomes compared with Gleason 4\u2009+\u20095: significance of Gleason 5 pattern. Ann Surg Oncol 20:3127\u20133132","journal-title":"Ann Surg Oncol"},{"key":"6418_CR30","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1016\/j.juro.2013.05.056","volume":"190","author":"CL Ellis","year":"2013","unstructured":"Ellis CL, Partin AW, Han M, Epstein JI (2013) Adenocarcinoma of the prostate with Gleason score 9\u201310 on core biopsy: correlation with findings at radical prostatectomy and prognosis. J Urol 190:2068\u20132073","journal-title":"J Urol"},{"key":"6418_CR31","unstructured":"Network N (2025) NCCN clinical practice guidelines oncology: prostate cancer. Version 2"},{"key":"6418_CR32","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1089\/end.2017.0723","volume":"32","author":"LM Huynh","year":"2018","unstructured":"Huynh LM, Ahlering TE (2018) Robot-assisted radical prostatectomy: a step-by-step guide. J Endourol 32:S28\u2013S32","journal-title":"J Endourol"},{"key":"6418_CR33","doi-asserted-by":"publisher","first-page":"3889","DOI":"10.21037\/tcr-23-2394","volume":"13","author":"K Nakane","year":"2024","unstructured":"Nakane K, Kawase M, Kato D et al (2024) Combination approach using neoadjuvant therapy with radical prostatectomy for improving oncological outcomes of high-risk prostate cancer: a narrative review. Transl Cancer Res 13:3889\u20133897","journal-title":"Transl Cancer Res"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-026-06418-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-026-06418-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-026-06418-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T15:49:10Z","timestamp":1776527350000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-026-06418-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,18]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6418"],"URL":"https:\/\/doi.org\/10.1007\/s00345-026-06418-w","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,18]]},"assertion":[{"value":"5 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures were in accordance with institutional\/national research committee standards and the 1964 Helsinki Declaration (and later amendments). The study was approved by the Institutional Review Board of Kyoto University Hospital (R3168).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The requirement for informed consent was waived owing to the retrospective study design.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"310"}}